We recently compiled a list of the 10 Stocks Lead Wednesday’s Charge, Mirror Broader Gains. In this article, we are going to ...
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .
Hosted on MSN14d
Why Moderna (MRNA) Stock Is Rallying TodayThe court ordered BNTX and PFE to furnish information about the revenue that it generated from selling their mRNA vaccine, Comirnaty. Moderna is seeking damages based on all sales of Comirnaty over ...
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
The second vaccine, developed by Moderna in partnership with the National Institute of Allergy and Infectious Diseases, got the greenlight from the FDA days later. These steps are now overlapping ...
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results